1. Home
  2. STXS vs SCPH Comparison

STXS vs SCPH Comparison

Compare STXS & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • SCPH
  • Stock Information
  • Founded
  • STXS 1990
  • SCPH 2013
  • Country
  • STXS United States
  • SCPH United States
  • Employees
  • STXS N/A
  • SCPH N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SCPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • STXS Health Care
  • SCPH Health Care
  • Exchange
  • STXS Nasdaq
  • SCPH Nasdaq
  • Market Cap
  • STXS 254.1M
  • SCPH 299.0M
  • IPO Year
  • STXS 2004
  • SCPH 2017
  • Fundamental
  • Price
  • STXS $3.09
  • SCPH $5.67
  • Analyst Decision
  • STXS
  • SCPH Buy
  • Analyst Count
  • STXS 0
  • SCPH 3
  • Target Price
  • STXS N/A
  • SCPH $12.00
  • AVG Volume (30 Days)
  • STXS 539.3K
  • SCPH 2.0M
  • Earning Date
  • STXS 11-10-2025
  • SCPH 11-12-2025
  • Dividend Yield
  • STXS N/A
  • SCPH N/A
  • EPS Growth
  • STXS N/A
  • SCPH N/A
  • EPS
  • STXS N/A
  • SCPH N/A
  • Revenue
  • STXS $31,806,000.00
  • SCPH $49,969,000.00
  • Revenue This Year
  • STXS $30.98
  • SCPH $104.30
  • Revenue Next Year
  • STXS $49.86
  • SCPH $76.06
  • P/E Ratio
  • STXS N/A
  • SCPH N/A
  • Revenue Growth
  • STXS 33.94
  • SCPH 107.79
  • 52 Week Low
  • STXS $1.54
  • SCPH $1.94
  • 52 Week High
  • STXS $3.59
  • SCPH $6.28
  • Technical
  • Relative Strength Index (RSI)
  • STXS 52.79
  • SCPH 64.40
  • Support Level
  • STXS $3.16
  • SCPH $5.64
  • Resistance Level
  • STXS $3.59
  • SCPH $5.65
  • Average True Range (ATR)
  • STXS 0.18
  • SCPH 0.03
  • MACD
  • STXS 0.02
  • SCPH -0.02
  • Stochastic Oscillator
  • STXS 33.78
  • SCPH 66.67

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.

Share on Social Networks: